References
- Alkodaymi MS, Omrani OA, Fawzy NA, et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect. 2022;28(5):657–666.
- Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601–615.
- World Health Organization. A clinical case definition of post COVID-19 condition by a delphi consensus, 6 october 2021. Geneva, Switzerland: World Health Organization; 2021. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.
- Korompoki E, Gavriatopoulou M, Hicklen RS, et al. Epidemiology and organ specific sequelae of post-acute COVID19: a narrative review. J Infect. 2021;83(1):1–16.
- Maltezou HC, Pavli A, Tsakris A. Post-COVID syndrome: an insight on its pathogenesis. Vaccines (Basel). 2021;9(5):497.
- Štěpánek L, Janošíková M, Štěpánek L, et al. The kinetics and predictors of anti-SARS-CoV-2 antibodies up to 8 months after symptomatic COVID-19: a Czech cross-sectional study. J Med Virol. 2022;94(8):3731–3738.
- Coronavirus disease (COVID-19). Symptoms [Internet]. Geneva, Switzerland: World Health Organization; 2021. Available from: https://www.who.int/health-topics/coronavirus#tab=tab_3.
- COVID-19. Symptoms of COVID-19 [Internet]. Atlanta, USA: Centers for Disease Control and Prevention; 2022. Available from: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html.
- World Health Organization [Internet]. Coronavirus disease (COVID-19): post COVID-19 condition. Geneva, Switzerland: World Health Organization; 2021. Available from: https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-post-covid-19-condition.
- Centers for Disease Control and Prevention. Long COVID or Post-COVID conditions. Atlanta (GA): Centers for Disease Control and Prevention; 2022. Available from: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html.
- COVID-19 Treatment Guidelines. Clinical spectrum of SARS-CoV-2 infection. Rockville (MD): National Institutes of Health; 2021. Available from: https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/.
- COVID-19 Panel. Dokumenty, pokyny. Prague, Czech Republic: Institute of Health Information and Statistics of the Czech Republic; 2022. Available from: https://www.uzis.cz/index.php?pg=covid-19.
- Mandrekar JN. Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol. 2010;5(9):1315–1316.
- Chen C, Haupert SR, Zimmermann L, et al. Global prevalence of post COVID-19 condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022;jiac136. DOI:10.1093/infdis/jiac136
- Fernández-de-Las-Peñas C, Palacios-Ceña D, Gómez-Mayordomo V, et al. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: a systematic review and meta-analysis. Eur J Intern Med. 2021;92:55–70.
- Arnold DT, Hamilton FW, Milne A, et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. 2021;76(4):399–401.
- Kim Y, Bitna H, Kim SW, et al. Post-acute COVID-19 syndrome in patients after 12 months from COVID-19 infection in Korea. BMC Infect Dis. 2022;22(1):93.
- Tleyjeh IM, Saddik B, AlSwaidan N, et al. Prevalence and predictors of Post-Acute COVID-19 Syndrome (PACS) after hospital discharge: a cohort study with 4 months median follow-up. PLoS One. 2021;16(12):e0260568.
- Zhang X, Wang F, Shen Y, et al. Symptoms and health outcomes among survivors of COVID-19 infection 1 year After discharge from hospitals in Wuhan, China. JAMA Netw Open. 2021;4(9):e2127403.
- Perlis RH, Green J, Santillana M, et al. Persistence of symptoms up to 10 months following acute COVID-19 illness. MedRxiv. 2021. DOI:10.1101/2021.03.07.21253072.
- Stavem K, Ghanima W, Olsen MK, et al. Prevalence and determinants of fatigue after COVID-19 in Non-Hospitalized subjects: a population-based study. IJERPH. 2021;18(4):2030.
- Goërtz YMJ, Van Herck M, Delbressine JM, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6(4):00542–2020.
- Moreno-Pérez O, Merino E, Leon-Ramirez JM, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J Infect. 2021;82(3):378–383.
- Štěpánek L, Janošíková M, Nakládalová M, et al. Relationship between acute-phase symptoms and immunoglobulin G seropositivity up to eight months after COVID-19. Medicina (Kaunas). 2022;58(6):708.
- Fernández-de-Las-Peñas C, Navarro-Santana M, Gómez-Mayordomo V, et al. Headache as an acute and post-COVID-19 symptom in COVID-19 survivors: a Meta-analysis of the current literature. Eur J Neurol. 2021;28(11):3820–3825.
- Hosseini P, Fallahi MS, Erabi G, et al. Multisystem inflammatory syndrome and autoimmune diseases Following COVID-19: molecular mechanisms and therapeutic opportunities. Front Mol Biosci. 2022;9:804109.
- Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021;53(10):737–754.
- Maamar M, Artime A, Pariente E, et al. Post-COVID-19 syndrome, low-grade inflammation and inflammatory markers: a cross-sectional study. Curr Med Res Opin. 2022;38(6):901–909.
- Cervia C, Zurbuchen Y, Taeschler P, et al. Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat Commun. 2022;13(1):446.